Drawing for AGE DOCTOR.COM

USPTO serial 78061194

AGE DOCTOR.COM

Reviewed by CopyMark Law Group

Status 614
Filing date
Status date
Registration date
—
Examiner
MAYS, PAULA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AGE DOCTOR.COM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Anti-aging cream Nutriceuticals for the treatment of Anti aging Nutriceuticals for use as a dietary supplement Nutritional drink mix for use as a meal replacement Nutritional supplementsACTIVE—
016Book Anti aging booksACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 27, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 11, 2002PETDPETITION TO REVIVE-DENIED—
Nov 13, 2002PETRPETITION TO REVIVE-RECEIVED—
Nov 13, 2002MAILPAPER RECEIVED—
May 4, 2002ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 28, 2001GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 23, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance